News for Tissue Regenix Group plc (TSSNF)

Revenue: Up 16% in the period.Gross Profit: Increased from 49% to 53%.Adjusted EBITDA Profit: $1.1 million, more than doubled from $0.9 million in 2023.Cash Po

Sep 10, 2024 / 03:30PM GMTOperator Good afternoon, and welcome to the Tissue Regenix Group plc interim results investor presentation. (Operator Instructions) Th

3D Systems is well-positioned to capitalize on the growing bioprinting industry, particularly in the field of 3D organ printing.

Mar 19, 2024 / 11:00AM GMTOperator Good morning, and welcome to the Tissue Regenix Group plc full year investor presentation(Operator Instructions) I'd now like

19 Mar 2024 Tissue Regenix Group plc , the regenerative medical devices company, announces its audited final results for the year ended 31 December 2023, with...

Tissue Regenix Group PLC on Tuesday said it was aiming for longer-term growth as it reported a sharp reduction in its annual losses. The Leeds, England-based medical devices company said pretax loss...

Sep 05, 2023 / 03:30PM GMTOperator Good afternoon, ladies and gentlemen. Welcome to the Tissue Regenix Group plc interim results investor presentation. (Operato

Sep 08, 2021 / 03:30PM GMTMarc Downes - Investor Meet Company - Moderator Good afternoon, ladies and gentlemen, and welcome to the Tissue Regenix Group plc inve

/PRNewswire/ -- The Global Soft Tissue Repair Market size is projected to grow by USD 3.42 billion, accelerating at a CAGR of over 4.5% during the forecast...

/PRNewswire/ -- The tissue engineering and regeneration market is expected to grow by USD 21.27 billion from 2022 to 2027. In addition, the momentum of the...